Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof

Details for Australian Patent Application No. 2006303809 (hide)

Owner Epipharm GmbH

Inventors Sift Carter, Rosemarie

Agent Davies Collison Cave

Pub. Number AU-A-2006303809

PCT Pub. Number WO2007/045116

Priority 686/05 20.10.05 CH; 514/06 30.03.06 CH

Filing date 19 October 2006

Wipo publication date 26 April 2007

International Classifications

A61K 31/335 (2006.01) - having oxygen as the only ring hetero atom, e.g. fungichromin

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61P 17/00 (2006.01) Drugs for dermatological disorders

Event Publications

12 June 2008 PCT application entered the National Phase

  PCT publication WO2007/045116 Priority application(s): WO2007/045116

26 July 2012 Alteration of Name

  The name of the applicant has been altered to Epipharm AG

2 August 2012 Amendment Made

  The nature of the amendment is: Amend the priority details to read 1686/05 20 Oct 2005 CH and 514/06 30 Mar 2006 CH 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006303810-Multimedia (Vo) IP solution for mobile telephones

2006303801-Device and method for the demodulation of modulated electromagnetic wave fields